This asset includes a set of proprietary technologies for the establishment of nutritional strategies adapted to the needs of the population based on genetic and microbiome studies. We identify biomarkers that, through targeted active compounds, can be modulated to achieve the prevention of chronic diseases.
• Genetic and microbiome diagnosis to establish the nutritional needs of different population cohorts.
• Digital platform aimed at the correlation between targeted active compounds and the modulation of biomarkers associated with the health status.
Bioinformatic analysis software and equipment from Life Technologies (QuantStudio Real Time PCR software v1.1) for analysis and interpretation of sequencing results
Illumina Miseq DNA Ultra-Sequencer for High Throughput and High Capacity DNA Sequencing (Latest Generation)
Liquid chromatography equipment coupled with high-resolution mass spectrometry and ionic mobility, from Bruker Española S.A. (TIMSTOF)
Minibio 500M bioreactor (4 mini reactors) from GETINGA (Applikon-My Control). Reactor with stirring and temperature control for selection of enzymes and establishment of enzymatic reactions
Sorvall BIOS16 centrifuge, from Thermo Fischer Scientific, enables high-quality bioprocessing methods of collection, separation, and purification that require reproducibility and traceability between runs
Formulation of ingredients
Genome study
Identification of targeted active compounds
Microbiome study
Precision nutrition
FUNDACIÓN TECNALIA RESEARCH & INNOVATION
Contact person: Mari-Carmen Villaran Velasco
Let us get to know you better. If you are looking to implement intelligent technologies and advanced materials that improve the efficiency of your company's production system to offer solutions with more added value, fill in this form.